Tag: Hedgehog pathway

Emerging Perspectives on the Antiparasitic Mebendazole as a Repurposed Drug for the Treatment of Brain Cancers

This 2023 review highlights the therapeutic potential of mebendazole (MBZ), a benzimidazole antiparasitic agent, as a repurposed drug for brain cancers, particularly glioblastoma and medulloblastoma. MBZ exerts anti-cancer effects by disrupting microtubule polymerization, inhibiting angiogenesis, inducing apoptosis, and modulating key oncogenic pathways such as Hedgehog signaling. Preclinical models demonstrate MBZ’s

Read More »